Recombinant Citrobacter koseri Thiol:disulfide interchange protein DsbD (dsbD)

What is the genomic context of the dsbD gene in Citrobacter koseri?

The dsbD gene in C. koseri is notably found within a specific genetic context. In carbapenem-resistant isolates, it has been identified as part of the ISKpn19-blaNDM-1-ble-tnpF-dsbD-cutA-ISKpn19 cassette array . This genomic arrangement provides important context for understanding the potential association between DsbD and antimicrobial resistance mechanisms. When studying the dsbD gene:

• Consider the complete genetic context rather than isolating the gene

• Assess the conservation of this genomic structure across different C. koseri isolates

• Evaluate potential co-transcription patterns with adjacent genes

• Investigate the possibility of horizontal gene transfer events that may have incorporated dsbD into this cassette

How does DsbD contribute to the pathogenicity of Citrobacter koseri?

C. koseri is an opportunistic pathogen capable of causing serious infections, particularly meningitis and brain abscesses in neonates and immunocompromised individuals . While specific research on DsbD's contribution to pathogenicity in C. koseri is limited, we can analyze its role based on established bacterial pathogenicity mechanisms:

• DsbD likely participates in maintaining proper protein folding in the bacterial periplasm

• As a thiol:disulfide interchange protein, it may be crucial for the structural integrity of secreted virulence factors

• It could be linked to stress response mechanisms that help the bacteria survive hostile host environments

• Its location in genetic islands associated with virulence genes suggests potential co-regulation with pathogenicity factors

Research indicates that C. koseri's unique pathogenicity is partly attributed to specific genetic elements like the high-pathogenicity island (HPI) cluster, which significantly enhances its ability to replicate in brain tissue and cause CNS infections . Investigating potential interactions between DsbD and proteins encoded by the HPI cluster could reveal important virulence mechanisms.

What are the optimal protocols for cloning and expressing recombinant C. koseri DsbD?

When working with recombinant C. koseri DsbD, consider the following protocol recommendations:

Cloning Strategy:

• Amplify the dsbD gene using high-fidelity DNA polymerase with primers designed to include appropriate restriction sites

• Include a C-terminal or N-terminal His-tag for purification, considering that N-terminal tags may interfere with the protein's signal sequence

• Consider using a pET expression system with T7 promoter for high-yield expression

• Optimize codon usage for E. coli if expression levels are low

Expression Conditions:

• Use E. coli BL21(DE3) or C41(DE3) for membrane/periplasmic protein expression

• Induce with 0.1-0.5 mM IPTG at reduced temperatures (16-25°C) to enhance proper folding

• Consider adding 0.2-0.5% glucose to the medium to reduce basal expression

• For membrane proteins, supplement with 1% glycerol to stabilize membrane fractions

Since DsbD is a thiol:disulfide interchange protein, particular attention should be paid to maintaining proper redox conditions during purification to preserve its native conformation and activity.

What analytical methods are most effective for assessing DsbD activity?

The assessment of DsbD's thiol:disulfide interchange activity requires specific methodologies:

In vitro Activity Assays:

• Thiol-disulfide exchange can be monitored using fluorescent probes sensitive to redox state changes

• Ellman's reagent (DTNB) can be used to quantify free thiol groups

• Mass spectrometry can identify the redox state of specific cysteine residues

• Enzyme-coupled assays linking DsbD activity to a detectable output (e.g., NADPH oxidation)

Structural Analysis:

• Circular dichroism (CD) spectroscopy to assess secondary structure changes upon substrate binding

• Intrinsic tryptophan fluorescence to monitor conformational changes

• Hydrogen-deuterium exchange mass spectrometry to identify dynamic regions

Interaction Studies:

• Pull-down assays with potential partner proteins

• Surface plasmon resonance (SPR) to measure binding kinetics

• Isothermal titration calorimetry (ITC) to determine binding thermodynamics

How can we determine the role of DsbD in C. koseri's adaptation to different host environments?

Investigating DsbD's role in bacterial adaptation requires multifaceted approaches:

Experimental Setup for Environmental Adaptation Studies:

• Generate dsbD knockout mutants using CRISPR-Cas9 or homologous recombination

• Compare growth kinetics of wild-type and ΔdsbD mutants under various stress conditions:

  • Oxidative stress (H₂O₂, paraquat)

  • pH stress (acidic and alkaline conditions)

  • Temperature stress

  • Nutrient limitation

  • Host-mimicking conditions (serum, tissue cultures)

• Perform transcriptomic analysis comparing gene expression patterns between wild-type and ΔdsbD strains

• Use fluorescent redox-sensitive probes to visualize changes in periplasmic redox state

In vivo Relevance Assessment:

• Animal infection models similar to those used for HPI cluster studies

• Tissue culture invasion and persistence assays

• Macrophage survival assays to assess intracellular persistence

• Biofilm formation capacity under different environmental conditions

What are the structural determinants of substrate specificity in C. koseri DsbD?

Understanding the structural basis of DsbD substrate specificity represents an advanced research question:

Structural Analysis Approaches:

• Generate a homology model based on known bacterial DsbD structures

• Use site-directed mutagenesis to identify critical residues for function

• Express individual domains of DsbD to assess their specific roles

• Perform molecular dynamics simulations to identify potential substrate binding sites

Experimental Validation:

• Cysteine-scanning mutagenesis coupled with activity assays

• Heterologous complementation with DsbD from other species

• Co-crystallization attempts with substrate proteins or peptides

• HDX-MS analysis of conformational changes upon substrate binding

How does C. koseri DsbD compare with homologs in other Enterobacteriaceae species?

DsbD is generally conserved across Enterobacteriaceae, but species-specific variations exist that may relate to pathogenicity differences:

Comparative Analysis Methods:

• Multiple sequence alignment of DsbD sequences from various Enterobacteriaceae

• Phylogenetic analysis to identify evolutionary relationships

• Domain architecture comparison to identify species-specific insertions or deletions

• Comparative structural modeling to identify surface property differences

The table below summarizes key differences in DsbD across clinically relevant Enterobacteriaceae:

What is the relationship between DsbD and antimicrobial resistance mechanisms in C. koseri?

The genomic context of dsbD in certain C. koseri isolates suggests potential links to antimicrobial resistance:

Research Approaches:

• Compare dsbD expression levels in resistant versus susceptible isolates

• Assess the impact of dsbD knockout on minimum inhibitory concentrations (MICs)

• Investigate potential co-regulation between dsbD and resistance genes

• Study the structural integrity of resistance-conferring enzymes in dsbD mutants

The presence of dsbD in the ISKpn19-blaNDM-1-ble-tnpF-dsbD-cutA-ISKpn19 cassette suggests a potential functional relationship with the NDM-1 metallo-β-lactamase, which confers resistance to carbapenems. This proximity may indicate:

• Potential co-selection of dsbD with resistance genes during antibiotic pressure

• Possible role in ensuring proper folding of NDM-1 and other resistance proteins

• Contribution to fitness cost compensation in resistant isolates

Unlike some Citrobacter species that produce chromosomal β-lactamases like class C enzymes (C. freundii) or class A enzymes like CKO-1 (C. koseri), the specific relationship between DsbD and these resistance mechanisms requires further investigation .

What animal models are most appropriate for studying DsbD's role in C. koseri pathogenicity?

Animal models for C. koseri pathogenicity studies should be selected based on the specific research questions:

Validated Animal Models:

• Neonatal rat model (2-day-old SD rats): Particularly useful for studying meningitis and brain abscess formation

• 18-day-old BALB/c mice: An alternative model that has been validated for C. koseri CNS infection studies

Methodological Considerations:

• For virulence studies, inoculation doses of ~5×10⁵ CFUs for 2-day-old SD rats and ~1×10⁷ CFUs for 18-day-old BALB/c mice have been established as effective

• Monitor bacterial counts in both blood and cerebrospinal fluid

• Assess bacterial replication capacity in brain tissue

• Compare wild-type and dsbD mutants for survival rate in infected animals

• Consider tissue-specific gene expression analysis using RT-qPCR

Research has demonstrated that deletion of virulence factors in C. koseri can lead to significantly decreased bacterial counts in CSF and reduced mortality rates in animal models . Similar approaches could be applied to study the impact of DsbD on pathogenicity.

How can transcriptomic and proteomic approaches enhance our understanding of DsbD function?

Multi-omics approaches provide powerful tools for comprehensive analysis of DsbD function:

Transcriptomic Approaches:

• RNA-Seq analysis comparing wild-type and dsbD mutant strains under various conditions

• Identification of differentially expressed genes in the dsbD regulon

• Transcript analysis under infection-relevant conditions

• Time-course expression studies during bacterial adaptation to stress

Proteomic Approaches:

• Comparative proteomics of wild-type versus dsbD mutants

• Redox proteomics to identify proteins with altered disulfide status

• Protein-protein interaction studies using pull-down assays coupled with mass spectrometry

• Secretome analysis to identify extracellular proteins affected by dsbD mutation

Integrated Analysis:

• Correlation of transcriptomic and proteomic data to identify post-transcriptional regulation

• Functional enrichment analysis to identify overrepresented biological processes

• Network analysis to identify central nodes in DsbD-dependent pathways

• Comparison with data from other Enterobacteriaceae to identify C. koseri-specific patterns